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Background: This study aims to assess postoperative hepatic growth of colorectal adeno-
carcinoma metastasis and peritumoural macrophage counts after laparoscopy in an experi-
mental animal model.
Methods: Thirty male syngenic WAG/Rij rats were randomised into two surgical groups:
laparoscopy (LS; n = 15) using CO2 at 12 mmHg and laparotomy (LT; n = 15; negative
control) during an operating time of 90 min. At 45 min after setup, CC531s colon adeno-
carcinoma cells were injected into two liver lobes. Postoperative tumour volumes were
determined by abdominal magnetic resonance imaging (MRI) and computed three-dimen-
sional volumetry. Peritumoural macrophages were counted by local stereology using a con-
focal laser-scanning ﬂuorescence microscope.
Results: The median postoperative tumour volume was signiﬁcantly higher after LS in both
lobes (L): after 10, 15 and 20 days in L2 and L5: 24/12, 54/38, 275/62 mm3 and 0/0, 15/11, 55/
24 mm3 (LS/LT). Signiﬁcantly fewer peritumoural macrophages were found after LS at all
postoperative time points (Mann–Whitney: p < 0.05).
Conclusions: Increased hepatic growth of colorectal adenocarcinoma metastasis and
impaired cellular antitumoural defence after LS cast doubt on the use of LS in colorectal
cancer and needs further clinical investigation.
Key Words: Colorectal carcinoma—Hepatic metastasis—Laparoscopy—Tumor growth—Anti-
tumoral immunological defense.
Laparoscopic colic or rectal resection as part of the
treatment for colorectal cancer has been adopted due
to several advantages over laparotomy, such as
shorter hospital stay, less postoperative pain and
faster convalescence.1–3
However, the inﬂuence of laparoscopy on intra-
hepatic colorectal tumour growth and antitumoural
immunological defence is still under debate. Large
clinical studies4–6 are still ongoing to establish the
clinical relevance of laparoscopy in colorectal cancer
treatment, but have not distinguished any signiﬁcant
impact on the outcome (5-year survival rate) com-
pared to laparotomy. A couple of experimental
Data have been presented at the 1st World Congress of Endo-
scopic Surgery, EAES, Berlin 2006.
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studies have assessed the inﬂuence of laparoscopy on
postoperative outcome of colorectal carcinoma using
various models. The assessment of haematogeneous
hepatic tumour spread in rats7,8 and mice9 and of
renal or cutaneous tumour growth after subcapsu-
lar10 or subcutaneous11 injection of colorectal carci-
noma cells have led to controversial for and against
arguments for the laparoscopic technique. Impor-
tantly, hepatic macrophages have been described as
playing a key oncological role in cellular antitu-
moural defence in respect of enhanced experimental
tumour growth following selective depletion of
phagocytotic cells.12,13 The inﬂuence of laparoscopy
on the number and function of macrophages is not
yet clear, although a lack of phagocytotic activity
during laparoscopy14 has been described and semi-
quantitative measurements of hepatic macrophages
in experimental colorectal hepatic metastases without
signiﬁcant difference between laparoscopy and lapa-
rotomy have been performed.8
Therefore, this study aims to assess the impact of
experimental laparoscopy on postoperative hepatic
growth of colorectal adenocarcinoma metastases and
numbers of peritumoural macrophages assessed by
MRI volumetry and immunoﬂuorescent microscopic
morphometry in a small-animal model.
MATERIAL AND METHODS
Animals
Thirty male WAG/Rij rats (a Wistar-derived
strain), weighing 290–320 g (Harlan, Horst, The
Netherlands), were used for all the experiments. They
were kept under specific pathogen-free (SPF) labo-
ratory conditions with a controlled climate and light
cycle and were fed a standard rat chow (Kliba Futter,
Basel, Switzerland) with sterile water ad libitum be-
fore surgery. The animals were given 2 weeks of ac-
climatisation time and fasted 6 h before surgical
intervention. The experiments were approved by the
animal ethics committee of the State of Fribourg and
performed according to international guidelines.
Tumour Cell Line
The CC531s cell line is a 1,2-dimethylhydrazine-
induced, moderately diﬀerentiated colon adenocarci-
noma cell line transplantable in syngenic WAG/Rij
rats. The cells were cultured in plastic culture ﬂasks
(75 cm2) in Roswell Park Memorial Institute Medium
1640 (RPMI 1640) medium supplemented with 20
mM 4-(2-hydroxyethyl)-1-piperazineethanesulfonic
acid (HEPES) buffer solution (Gibco, Invitrogen
Ltd., Basel, Switzerland), 50 lg/mL streptomycin
and 50 U/mL penicillin and 10% foetal calf serum
(Amimed, Allschwil, Switzerland) at 37C in 5% CO2
atmosphere. After 55 passages, in vitro cells were
washed with phosphate-buffered saline solution
Hanks balanced salt solution (HBSS) (Gibco, Invit-
rogen Ltd., Basel, Switzerland), trypsinised with
Trypsin/diaminoethanetetraacetic acid (EDTA)
(Gibco, Invitrogen Ltd., Basel, Switzerland) for 5 min
at 37C and centrifuged for 6 min at 290 g. After
resuspension in RPMI 1640 medium, the number and
viability of the tumour cells were measured using the
trypan blue method. Viability always exceeded 95%.
The cell suspension was diluted using RPMI 1640
medium and fractioned to obtain 200 lL samples
containing 500,000 CC531s cells each and used for
subcapsular hepatic in vivo injection within 15 min of
cell harvesting.
Study Design
Thirty rats were randomised into two surgical
groups: CO2 laparoscopy (n = 15) as the experi-
mental group and laparotomy (n = 15) as the con-
trol group. At 10, 15 and 20 days after surgery, the
animals were characterised by body weight, liver
weight and volume and by the tumour volume by
MR imaging, including computed 3D volumetry and
peritumoural count of macrophages by local stere-
ology on confocal laser-scanning microscopic images.
Surgical Procedures and Anaesthesia
The animals were anaesthetised by inhaling a
mixture of isoﬂurane and oxygen (0.5–5% isoflurane
complemented with pure oxygen) using a conven-
tional vaporiser and a table-fixed animal mask
(Provet AG, Lyssach, Switzerland). After induction
of narcosis in the induction box, the animals were
secured in a supine position on a small-animal oper-
ating table and then shaved. The overall operating
time was 90 min.
A pneumoperitoneum was provided by a CO2
insufﬂator (Aesculap, Tuttlingen, Germany). To
avoid intra-abdominal pressure ﬂuctuation due to
instrument and trocar movements, a 5-L gas tank was
placed between insufﬂator and the abdominal cavity.
Laparoscopic imaging was performed by a 30 4 mm
arthroscope with a 4.5 mm trocar sleeve (Aesculap,
Tuttlingen, Germany) and laparoscopic manipula-
tions using two 3 mm trocars (working channels) and
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2.7 mm instruments (scissors, straight forceps; Wolf,
Tuttlingen, Germany) introduced under endoscopic
guidance. Intra-abdominal hepatic tumour cell inoc-
ulation began with the blunt preparation of liver
lobes 2 (distal from portal vein) and 5 (proximal to
portal vein) using 5 mm cotton swabs to move the
intestines. Three cotton swabs were smoothly placed
on the liver and kept ready to stop possible bleeding.
A 12-cm-long catheter (needle and adaptor: LUER
Lock 0.4x12 mm, silicone tubing 0.6 mm OD; Ulrich
AG, St. Gallen, Switzerland) was introduced to the
abdominal cavity by a 2 mm abdominal wall incision
at the right lower abdomen. The incision was
clamped to avoid gas leakage. At 45 min after setup,
500,000 CC531s tumour cells in 200 lL RPMI 1640
were inoculated by tangential subcapsular15 hepatic
injection via needle-armed catheter. The catheter was
only retracted 5 min later to avoid a backﬂow of the
cell suspension. Finally, all trocar sleeves were re-
moved under endoscopic view to exclude possible
bleeding. The wounds then were closed with two
absorbable stitches by 3/0 Vicryl.
Open laparotomy as a control was provided by a
standardised 5 cm midline incision and the abdomi-
nal wall was retracted using hooks (made of ordinary
paperclips) and rubber bands ﬁxed to a metal arch
positioned across the rat. Ordinary small-sized hand
surgery instruments were used for all open proce-
dures. Tumour cell inoculation was performed
applying the same time point and technique as during
laparoscopy. The abdominal cavity was protected
with moistened sterile gauze during the absence of
surgical manipulation. The wound was closed with 3/
0 Vicryl running sutures in two layers.
Magnetic Resonance Imaging and Computed Three-
Dimensional Volumetry
Following euthanasia, immediate MR tomography
was performed in a Somatom Vision (1.5 Tesla, Sie-
mens, Erlangen, Germany) using an MRI wrist coil
followed by liver explantation and tissue harvesting.
Hepatic tumour nodules in lobes 2 and 5 were de-
tected by postinterventional computed three-dimen-
sional reconstruction and the median tumour volume
was determined in mm3.
Tissue Preparation
MR imaging was followed by immediate liver
explantation. The livers were weighed (in grams) and
the liver volume was measured by water displacement
(in mm3). The liver lobes 1–5 were dissected, washed
in phosphate buffered saline (PBS) solution and kept
in paraformaldehyde (Fluka, Buchs, Switzerland)
until lobes 2 and 5 were processed by the cryostat.
Liver cryostat sections of 40 lm were air dried for 12
h and fixed in acetone for 10 min at room tempera-
ture. Standardised immunohistochemical analysis
was performed using a conventional staining ma-
chine.
Immunohistochemical Analysis
Primary mouse anti-rat ED 1 monoclonal antibody
(mAb) reacting, with a single-chain glycoprotein that
is expressed predominantly on the lysosomal mem-
brane of myeloid cells, was used for a general staining
of tissue macrophages as well as freshly homed
monocytes (Serotec Ltd., Oxford, UK). mAb were
tested for their correct staining reaction in a pilot
sample and immunohistochemical protocols were
adapted to obtain a maximal quality of staining.
Cryostat sections were incubated overnight at 4C
with mouse anti-rat ED1 mAb (1:1500, TBS + 0.1%
Triton + 10% SB; Serotec Ltd., Oxford, UK). After
rinsing three times with TBS for 5 min, sections were
incubated for 4 h with goat anti-mouse ﬂuorescein-5-
isothiocyanate (FITC) (Tris pH 8.2, 1:100; Serotec
Ltd., Oxford, UK). After rinsing three times with
TBS for 5 min, sections were developed by incubating
for 10 min with propidiumiodide (1 mg/100 ml PBS
pH 7.3; Serotec Ltd., Oxford, UK).
After rinsing with TBS (pH 7.3) for 10 min, sec-
tions were mounted with Slow Fade (Molecular
Probes, Leiden, The Netherlands).
Confocal Microscopy and Local Stereology
for Peritumoural Macrophage Count
A transtumoural 40 lm cryosection in both lobes
was sampled at the each tumours largest diameter
and analysed by a confocal laser-scanning micro-
scope (Eclipse 800, Nikon, Germany/Bio Rad
Microscopy Division, Herts, UK) after staining.
Macrophages were quantiﬁed within ﬁve peritumo-
ural and ﬁve parenchymateous counting frames
over ﬁve optical plains with an in-between distance
of 2 lm (volume of assessed cubes:
80 · 80 · 10 lm). These frames were sampled as
shown in Fig. 1, Fig. 2, Fig. 3, Fig. 4: a basic axis
through a random point within the tumour nodule
and orthogonal to the livers surface was selected.
Furthermore, at ±30 and ±60, additional axes
were selected running through the same random
point. At the cross section of these axes with the
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tumour borders, the ﬁve peritumoural counting
ﬁelds and at a radial distance of 160 lm from the
tumours margin, ﬁve parenchymateous counting
ﬁelds were deﬁned (see Fig. 4). The median number
of macrophages within the peritumoural and pa-
renchymateous volumes was analysed. Importantly,
only the overlay of a propidiumiodide-stained nu-
cleus with the ED1-stained cytoplasma was con-
sidered to be a macrophage and omitted in
subsequent planes to avoid bias.
Statistical Methods
Liver weights and volumes are presented as
mean ± standard deviation (SD). Means between
the two groups (laparoscopy versus laparotomy) were
compared by Students t-test after having tested for
normal distribution.
Tumour volumes and macrophage counts are given
as median values. Signiﬁcance testing between the two
groups was performed by the Mann–Whitney test.
Analysis of tumour volumes between the two lobes (2
FIG. 1. Median tumour volumes of hepatic colorectal adenocarcinoma nodule in liver lobe 2 (Fig. 1A) and lobe 5 (Fig. 1B) in mm3 at 10, 15
and 20 days after CO2 laparoscopy (green) and laparotomy (control, red) measured by immediate post-mortem MR imaging and consecutive
computed three-dimensional reconstruction and volumetry (n = 5); p < 0.05 for differences between the surgical groups at any time point in
lobe 2, and for 15 and 20 days after laparoscopy in lobe 5 (Mann–Whitney test).
FIG. 2. Median number of hepatic peritumoural (A) and parenchymal (B) macrophages within liver lobe 2 in count/5120 mm3 10, 15 and 20
days after CO2 laparoscopy (green) and laparotomy (control, red) measured by speciﬁc immunohistological staining and morphometric
analysis using confocal ﬂuorescent laser-scanning microscopy (n = 5); p values < 0.05 for differences between laparoscopy and laparotomy
at any time point (Mann–Whitney test).
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and 5) as well as the macrophage counts between the
peritumoural and parenchymal areas at a certain time
point were provided by an unpaired t-test.
Signiﬁcance was accepted in all cases at p < 0.05.
All statistical procedures were performed using
SPSS for Windows (SPSS Science International,
Chicago, Illinois, USA).
RESULTS
The mean body weight of the rats at the time point
of surgery was 268 ± 37.6 g in animals undergoing
laparotomy and 281 ± 27.9 g in the laparoscopic
group. There was no signiﬁcant diﬀerence between
the surgical groups (p > 1).
The mean total liver weights ranged from
11.4 ± 2.1 g to 14.1 ± 1 g, the mean total liver
volumes ranged from 10.5 ± 2 cm3 to 13.1 ± 0.9
cm3, the mean volume of the livers second lobe
ranged from 3.7 ± 0.6 cm3 to 4.7 ± 0.3 cm3 and the
mean volume of the ﬁfth liver lobe ranged from
0.4 ± 0.2 cm3 to 0.7 ± 0.2 cm3 (see Table 1).
However, there were no signiﬁcant differences for
these values between the surgical groups at any
postoperative time point (p > 1).
FIG. 3. Conventional and 3D-MR imaging of hepatic colorectal adenocarcinoma metastasis: (A) immediate post-mortem conventional MR
imaging and (B) three-dimensional computed reconstruction of hepatic colorectal adenocarcinoma metastasis of the CC531s cell line in WAG/
Rij rats after subcapsular cellular injection during CO2 laparoscopy at 12 mmHg intra-abdominal pressure 20 days before imaging.
FIG. 4. Histological sampling for confocal laser scanning morphometry. (A) Histological haematoxylin–eosin-stained section of a hepatic
CC531s colon adenocarcinoma metastasis () and schematic counting frames for morphometric analysis within peritumoural (1–5) and
parenchymal (6–10) counting fields. (B) Fluorescent immunohistological staining for macrophages (primary antibody ED1; Serotec/pro-
pidiumiodide) in a counting frame within a counting region for three-dimensional quantification of macrophages () over a depth of 10 lm
by fluorescent confocal laser-scanning microscope.
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The median nodular volume of colorectal adeno-
carcinoma metastases after CO2 laparoscopy was
signiﬁcantly higher than after laparotomy at any
measured time point following surgery in hepatic lobe
2 and at 15 and 20 days after surgery in hepatic lobe 5
(p < 0.01; Mann–Whitney test). All animals of either
group developed tumours in lobe 2 and all animals of
either group sacrificed at 15 and 20 days after surgery
developed tumours in lobe 5. However at 10 days
after surgery, in only one of five animals of either
group was a tumour nodule detected in lobe 5 by
both MRI and histological assessment (volume after
LT 7 mm3; after LS 15 mm3). 20 days after surgery,
the tumour volume after laparoscopy was four times
higher in lobe 2 and more than double in lobe 5
compared to laparotomy. Furthermore, the tumour
volumes were signiﬁcantly higher in lobe 2 compared
to lobe 5 in both groups at any time point (p < 0.05,
unpaired t-test).
The median number of hepatic macrophages in
lobe 2 within the peritumoural as well as the paren-
chymal counting ﬁelds was signiﬁcantly lower after
CO2 laparoscopy than after laparotomy at all time
points after surgery (p < 0.01, Mann–Whitney test).
Histological quantification of macrophages in lobe 5
was omitted due to a lack of stereological reference
due to undetectable tumour nodules 10 days after
surgery. No significant difference between peritumo-
ural and parenchymateous counting was detected
(p < 0.05, unpaired t-test).
DISCUSSION
In the present study, the overall postoperative tu-
mour growth of hepatic metastasis of colorectal
adenocarcinoma after experimental laparoscopy in
rats was signiﬁcantly increased and associated with a
lower peritumoural macrophage count than after
laparotomy up to 20 days after surgery, with a lack of
signiﬁcant diﬀerence in preoperative bodyweight or
postoperative liver weight and volume at the time
point of MRI and liver explantation between the
surgical groups.
To imitate abdominal surgery (laparoscopy/lapa-
rotomy) in patients suﬀering from colonic or rectal
adenocarcinoma with hepatic metastases, preference
was given to the subcapsular hepatic injection of
CC531s colon adenocarcinoma cells. Previous appli-
cations of the CC531s model in experimental lapa-
roscopy were performed by intrasplenic7 or
intraportal8,9 injection of the tumour cells, leading to
multiple hepatic metastases after haematogeneous
spread. In contrast, CC531s cells were injected sub-
capsularly in a nonsurgical oncological study to in-
duce well-localised and accessible liver metastases.16
However, the present study combines the two tech-
niques in order to avoid multiple haematogeneous
hepatic tumour seeding and to focus on the postop-
erative development of single, well-localised hepatic
colorectal metastases. Technically, the model of
experimental laparoscopy previously described17,18
was slightly modiﬁed: intra-abdominal pressure ﬂuc-
tuations during laparoscopy were equilibrated by a 5-
L gas tank between the inﬂator and the abdominal
cavity in accordance with the average human intra-
abdominal volume and the performance of subcap-
sular injection by a ﬂexible silicone catheter with a
metallic needle point instead of a syringe with a rigid
needle-top provoking a pressure on the inﬂated
abdomen7,8 in the moment of tumour cell inocula-
tion. Previous semiquantitative tumour measures
(Steller Score, cancer index7 or metastatic index18,19)
were replaced by quantitative volumetry by MR
imaging.
TABLE 1. Mean total liver weight, total liver volume and volume of hepatic lobes 2 and 5
10 days post-op. 15 days post-op. 20 days post-op.
Total liver weight (g)
Laparotomy 11.42 ± 2.1 12.44 ± 1.38 13.16 ± 1.16
Laparoscopy 12.04 ± 0.71 13.04 ± 1.15 14.14 ± 0.99
Total liver volume (cm3)
Laparotomy 10.52 ± 2.02 11.58 ± 1.41 12.16 ± 1.13
Laparoscopy 12.18 ± 0.61 12.85 ± 1.08 13.10 ± 0.92
Volume of hepatic lobe 2 (mm3)
Laparotomy 3.7 ± 0.6 4.1 ± 0.4 4.3 ± 0.5
Laparoscopy 4.1 ± 0.5 4.4 ± 0.4 4.7 ± 0.3
Volume of hepatic lobe 5 (mm3)
Laparotomy 0.4 ± 0.2 0.7 ± 0.1 0.7 ± 0.1
Laparoscopy 0.7 ± 0.7 0.7 ± 0.1 0.7 ± 0.2
There was no signiﬁcant diﬀerence in mean total liver weight, total liver volume or lobal volume 2 or 5 between the two groups at any time
point after surgery (p > 1; Students t-test after testing for normal distribution).
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Regarding pathophysiological and tumour biolog-
ical aspects, the method of subcapsular hepatic tu-
mour cell injection is highly debatable: in the event of
open or laparoscopic resection of colorectal cancer
and the postoperative formation of hepatic metasta-
ses eventual pre- or perioperative tumour cell seeding
most probably occurs mainly due to haematogeneous
or lymphogeneous spreading. This aspect is com-
pletely lost by injecting tumour cells subcapsularly
and directly into the hepatic tissue. Subcapsular
inoculation furthermore confronts the liver with a
localised exorbitantly high load of viable tumour
cells, which probably would never reach peripheral
hepatic areas in such high concentrations after hae-
matogeneous spreading, omitting the process of ha-
ematogeneous tumour cell spillage with distribution
throughout the whole liver and the event of diape-
desis (extra-vascularisation of cells). Therefore, pre-
viously described models with intraportal8,9 or
intrasplenic7 injection followed by haematogeneous
spread appear to represent the pathophysiological
mechanism of colorectal tumour cell spillage more
reliably. On the other hand, the subcapsular model
might serve to imitate the fact of pre-existing or
dormant micrometastases at the tim-point of surgery
and to observe their postoperative development after
open or laparoscopic surgery (e.g. colon resection).
Unfortunately, this studys model applies the deter-
mining surgical technique (laparoscopy versus lapa-
rotomy) synchronically to the tumour cell injection.
Hence the tumour nodules cannot be present and
established at the time point of variable surgical
application and remain difﬁcult to be considered as
pre-existing or dormant metastases. Furthermore,
interpreting the impact of a surgical method on a
metastasis that effectively is not yet established at the
time point of surgery is debatable and rather vague.
Ideally, the injection and formation of metastases
should take place before surgery, as provided by
Schmeding et al.20 Another source of error may be
the quality of inoculation, depending on the tech-
nique of injection. If the needle is retracted too early
an inevitable reﬂux of tumour cells impairs the
quality of inoculation by a decreased number of cells
injected. Finally, it remains uncertain whether a 90
min exposition to laparoscopic or open surgery might
result in a signiﬁcantly different inﬂuence on tu-
mours biology with an impact on postoperative tu-
mour growth up to 20 days after surgery.
The postoperative development of hepatic metas-
tases within the present study showed an overall
tendency of signiﬁcantly increased growth after lap-
aroscopy compared to laparotomy up to 20 days after
surgery and signiﬁcantly higher tumour growth in
lobe 2 compared to lobe 5. However, in lobe 5 after
10 days four of ﬁve animals in either surgical group
failed to develop any MR or histologically detectable
tumour nodule in contrast to all other animals with
well-established postoperative tumours in both lobes.
Apparently, the quality of injected cells, although
tested for viability, or of the injection technique into
lobe 5 might not have been to the highest standards,
although the corresponding animals displayed well-
developed tumours in lobe 2. This unexpected lack of
tumour growth most probably occurred for a tech-
nical reason and indicates how delicate and fragile the
model appears to be and as a consequence how dif-
ﬁcult it remains to exclude uneven tumour growth
due to failed or incomplete cellular implantation.
Nevertheless, in the following sections the tendency
of an overall increased tumour growth after lapa-
roscopy is considered justiﬁed.
The most comparable experimental study was
provided by Gutt et al.8 by intraportal injection of
CC531s adenocarcinoma cells during CO2 laparos-
copy and laparotomy, which resulted in no signiﬁcant
difference in postoperative tumour growth between
the surgical groups in contrast to this studys ﬁndings
of increased growth after laparoscopy. Possibly, the
induction of two single metastases compared to the
affection of the entire liver in Gutts study is related
to a sensitivity to the surgical technique which is
absent at a certain tumour load and amount of dis-
ease. In this case the more determining factor seems
to be the number of tumours instead of the surgical
technique, and the situation of single metastases may
differ completely from the situation of multilobar
hepatic tumour spread. Else, in Gutts study, the use
of semiquantitative macroscopic and microscopic
analysis of the tumour load omitting intraparenchy-
mal lesions and applying nonstereological mor-
phometry might also be a source of error. However,
the subcapsular technique also has a certain potential
of errors due to inefﬁcient inoculation and the ab-
sence of haematogeneous intrahepatic distribution of
the tumour cells, as demonstrated by the unexpected
failure of tumour growth in lobe 5 at 10 days after
surgery in eight animals. In another study, Gutt et
al.7 induced abdominal tumours by cell injection into
the spleen. No signiﬁcant difference in tumour load
was found between laparotomy and CO2 laparoscopy
in the liver. Intrasplenic injection resulted in hae-
matogeneous tumour cell spillage through the splenic
and portal vein, leading to multiple hepatic metas-
tases as seen in the study before.7 Apparently, the
same difﬁculties of comparison arise as the situation
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of total hepatic cancerous affection seems to differ
from the state of solitary metastases, and semiquan-
titative measures are unequal to the quantitative
stereological measures of the present study. A
favourable oncological outcome after CO2 laparos-
copy was detected by Bouvy et al.10 and Lee et al.11
Bouvy administered the tumour cells both into the
abdominal cavity and under the renal capsule, omit-
ting the haematogeneous factor and focusing on a
well-localisable subcapsular renal tumour nodule.
Interestingly, subcapsular injection and consecutive
elevated intra-abdominal pressures resulted in less
severe tumour growth than did open surgery, al-
though Bouvy used the kidney instead of the liver and
thus focused on a retroperitoneal site. However, this
model might be of importance when it comes to
metastases per continuitatem with direct retroperi-
toneal invasion of the primary colon tumour. Further
immunological assessments were not provided and
therefore the inﬂuence of the renal tissue and immu-
nological factors remain unclear. At any rate, this
model demonstrates the potential aggression of
CC531s cells even in nonhepatic tissue and conﬁrms
the potential of these cells for malignant inoculation
after subcapsular interstitial administration. As the
present study intends to imitate the clinical situation
of laparoscopy in manifest or dormant hepatic colo-
rectal metastases, despite the ambivalence of syn-
chronic injection and pneumoperitoneum, a trial
assessing the inﬂuence of laparoscopy on pre-existing
metastases would be of great interest. The present
state of literature does not reveal any satisfactory
study other than a publication by Schmeding et al.20
on tumour recurrence after curative partial liver
resection in localised, induced hepatocellular carci-
noma. This is the only study documenting the inﬂu-
ence of laparoscopy on pre-existing hepatic tumour in
an experimental model. Schmeding did not detect any
signiﬁcant difference in tumour recurrence at the
hepatic site of resection between laparotomy or CO2
laparoscopy. On the contrary, he found helium lap-
aroscopy to be the most protective technique with the
least local tumour recurrence after curative resection.
Although Schmedings tumour cell line, injection and
surgical techniques and animal model differ from the
present study, it remains of great interest regarding
the impact of laparoscopy on pre-existing hepatic
tumours.
Macrophages play a key role in cellular antitu-
moural immunological defence in the early onset of
hepatic colorectal carcinoma metastases, as shown by
selective depletion of macrophages (including Kupf-
fer cells in the liver) associated with an increased
hepatic growth of colorectal metastases12,13 and
activation of macrophages leading to enhanced tu-
mour growth.21 The cellular interaction between co-
lonic tumour cells and hepatic macrophages with the
CC531s tumour cell line was conﬁrmed by Timmers
et al. using immunoﬂuorescent microscopy in an
early tumoural onset study.22 Timmers et al. applied
an intravenous cell inoculation with haematogeneous
tumour spillage, limiting their experiments to the ﬁrst
24 h after injection, and did not include any laparo-
scopic approach. These points differ completely from
the design of the present study and do not facilitate
comparison of the cellular immunological response.
While Timmers et al. concentrated on cellular inter-
action and phagocytotic function rather than num-
bers of macrophages, Heuff et al.12 as well as Bayon
et al.13 deﬁned phagocytotic populations and per-
formed semiquantitative measures in purely onco-
logical experimental studies. Heuff et al.,12 besides
enhanced tumour growth after selective macrophage
depletion, found a marked increase in the total
macrophage population as well as the tissue-resident
subpopulation in the liver parenchyma 2 weeks after
tumour injection. As a consequence, the number of
freshly homed macrophages was also elevated. These
immunological cells were mainly located in the portal
and central areas. There was no peritumoural
assessment. Bayon et al.13 reported the same ﬁndings
with over 75% of freshly homed macrophages among
the macrophages with intratumoural localisation at 2
as well as 14 days after inoculation. No peritumoural
inﬂammatory corona was detected and no paren-
chymal macrophage assessment in the normal liver
tissue was provided. Regarding the high impact of
freshly homed macrophages on antitumoural immu-
nological defence up to 2 weeks after injection com-
pared to the population of tissue resident
macrophages (Kupffer cells) disclosed in the Bayon
and Heuff studies, only general macrophage staining
was provided in the present study. Although the
other two studies mentioned do not refer to any
laparoscopic technique, an enhanced tumour growth
after laparoscopy might be explained by associated
decreased numbers of peritumoural and parenchymal
macrophages. Importantly, Gutt et al.8 in their
semiquantitative analysis of hepatic colorectal tu-
mour growth and accompanying Kupffer cells after
laparoscopy found no difference in Kupffer cell count
at an indifferent tumour load after laparoscopy and
laparotomy. These ﬁndings differ from the increased
tumour volumes and lower macrophage counts after
laparoscopy in the present study. This discrepancy
might again occur due to haematogeneous tumour
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cell spillage into all liver segments causing a com-
pletely different immunological situation within the
hepatic tissue. The measurement took place 28 days
after surgery, whereas the latest time point of mea-
surement in the present study was at 20 days after
surgery only. Possibly, a direct inﬂuence of laparos-
copy on tissue resident macrophages might have been
equilibrated by 28 days after surgery. Methodologi-
cally, nonstereological semiquantitative macrophage
analysis might be another reason of discrepant re-
sults, or the semiquantitative measures were provided
by staining of tissue-resident macrophages (Kupffer
cells) omitting freshly homed macrophages. This
might explain why the macrophage count of the
present study, including all kinds of macrophages
(tissue-resident and freshly homed), after laparoscopy
turns out to be higher than after laparotomy. How-
ever, as Bayon et al.13 documented over 75% freshly
homed macrophages, despite a mostly intratumoural
measurement, this subpopulation appears to play an
important role in antitumoural cellular defence.
Furthermore, to date no quantitative differentiation
between macrophage count directly attached to the
tumour and within the remnant parenchymal liver
tissue has been performed and the absence of a sig-
niﬁcant difference in the present study implies the
absence of an overshooting immunological corona
around the tumour, which is perfectly in accordance
with the ﬁndings of Bayon et al. 14 days after tumour
injection.13 The absence of a signiﬁcant difference in
macrophage numbers around the tumour compared
to the remnant liver tissue might indicate a generally
modiﬁed overall hepatic antitumoural cellular re-
sponse after laparoscopy compared to laparotomy
instead of a local immunological inﬂuence. As pre-
vious studies could not distinguish any postoperative
difference in tumour load nor macrophage counts
after laparoscopy and laparotomy,8 the impact of
laparoscopy and CO2 detected in the present study
might be irrelevant for larger amounts of disease all
over the liver, although an impaired immunological
reaction would neatly explain a greater tumour load.
In conclusion, MR tumour volumetry and stere-
ological immunological analysis in an animal model
resulted in an increased overall postoperative tumour
growth associated with decreased numbers of hepatic
macrophages after experimental CO2 laparoscopy.
Although previous studies could not distinguish any
difference in tumour growth and antitumoural cel-
lular defence after haematogeneous tumour cell
spillage over the entire liver and though the inﬂuence
of 90 min of laparoscopy on tumour growth and
immunological response up to 20 days postopera-
tively is debatable, the present signiﬁcant postopera-
tive unfavourable oncological tendency in solitary
metastases questions the safety of experimental lap-
aroscopy in manifest or potential hepatic metastases.
Further experimental studies on the regulation of the
cellular immunological and tumoural hepatic reac-
tion as well as clinical studies are needed to answer
the question of whether to provide laparoscopy or
open surgery in patients with hepatic colorectal
metastases.
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